Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-4-20
|
pubmed:abstractText |
The influence of different fibrates on apolipoprotein metabolism was investigated. Administration of fenofibrate provoked a dose-dependent decrease in plasma cholesterol concentration that was already evident after 1 day. Intestinal apolipoprotein (apo) A-I and apo A-IV mRNA levels remained fairly constant. In contrast, liver apo A-I, apo A-II, and apo A-IV mRNA levels decreased in a dose-dependent fashion, which was associated with a lower transcription rate of the apo A-I but not the apo A-II gene. The decline in hepatic apo A-I, apo A-II, and apo A-IV mRNA had already started after 1 day and was associated with a drop in plasma apo A-I and apo A-IV concentrations. Plasma apo E had already decreased after 1 day of fenofibrate, whereas apo B initially remained constant and increased only after 14 days of fenofibrate at the highest dose. Hepatic and intestinal apo B mRNA contents and liver, heart, kidney, and testis apo E mRNA contents were only marginally affected after treatment with fenofibrate. Liver low density lipoprotein receptor mRNA levels rose slightly after a 3-day administration of the highest dose of fenofibrate. Both clofibrate and gemfibrozil had effects comparable to those of fenofibrate on liver and intestinal apolipoprotein mRNA levels except for liver apo A-II mRNA, which decreased only marginally. Compared with fenofibrate, clofibrate caused similar changes in plasma cholesterol, apo A-I, apo A-IV, and apo E concentrations, whereas gemfibrozil increased plasma cholesterol and apo E without changing apo A-I and apo A-IV concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-II,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins A,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E,
http://linkedlifedata.com/resource/pubmed/chemical/Clofibrate,
http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/apolipoprotein A-IV
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1049-8834
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
286-94
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1547188-Animals,
pubmed-meshheading:1547188-Apolipoprotein A-I,
pubmed-meshheading:1547188-Apolipoprotein A-II,
pubmed-meshheading:1547188-Apolipoproteins,
pubmed-meshheading:1547188-Apolipoproteins A,
pubmed-meshheading:1547188-Apolipoproteins B,
pubmed-meshheading:1547188-Apolipoproteins E,
pubmed-meshheading:1547188-Clofibrate,
pubmed-meshheading:1547188-Fenofibrate,
pubmed-meshheading:1547188-Gene Expression,
pubmed-meshheading:1547188-Intestines,
pubmed-meshheading:1547188-Kinetics,
pubmed-meshheading:1547188-Liver,
pubmed-meshheading:1547188-Male,
pubmed-meshheading:1547188-RNA, Messenger,
pubmed-meshheading:1547188-Rats,
pubmed-meshheading:1547188-Rats, Inbred Strains,
pubmed-meshheading:1547188-Transcription, Genetic
|
pubmed:year |
1992
|
pubmed:articleTitle |
Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat.
|
pubmed:affiliation |
Laboratorium voor Experimentele Geneeskunde en Endocrinologie, Katholieke Universiteit Leuven, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|